Homestemix Inc. | Jushi Holdings Inc.

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce the Journal of Biomedical Research and Environmental Sciences published the Company’s Phase II randomized clinical trial results today. The publication highlights the results of no option critical limb ischemia patients who started the clinical trial with an ulcer, comparing wound healing, amputation, and mortality between the patients treated with ACP-01 and patients treated with a placebo. Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, applauded Governor Shapiro’s continued advocacy for a comprehensive policy for cannabis, including legal adult-use sales. Jim Cacioppo, Chief Executive Officer, Chairman and Founder of Jushi, commented, "The message is clear that the public wants a legal, regulated adult-use cannabis marketplace." For more information, please visit StockDayMedia.com Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy